Marcel R. M. van den Brink - Next Frontiers to Cure Cancer 2021

Marcel R. M. van den Brink

Memorial Sloan Kettering Cancer Center

Marcel van den Brink is a physician scientist and medical oncologist who performs both laboratory and
clinical research related to allogeneic bone marrow transplantation (BMT) and immuno-oncology. He is
the Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center
(MSKCC) and holds a joint appointment in the Immunology and Transplantation Program of the Sloan
Kettering Institute. He is the Co-Director of the Parker Institute for Cancer Immunotherapy at MSKCC
and Chairman of the Board of DKMS, an international nonprofit organization devoted to bone marrow
donor registration. As a clinical scientist, he is involved in immunotherapeutic trials of cytokines, cell
therapies, as well as strategies to manipulate the intestinal microbiome for patients with hematologic
malignancies. His laboratory is devoted to the immunology of BMT and he studies immune
reconstitution, pathophysiology of graft-versus-host disease, the intestinal microbiota, and chimeric
antigen receptor T cells in patients and preclinical models. Both as a Division Head and a laboratory
Principal Investigator, he mentors junior faculty members, hematology oncology fellows, postdoctoral
fellows, graduate students, and undergraduate students.